MiR-29c Alleviates Hyperglycemia-Induced Inflammation via Targeting TGF-β in Cardiomyocytes

In vitro experiments, researchers transfected miR-29c mimic and antagomir into HL-1 cells to explore the effect of miR-29c on inflammation in hyperglycemic conditions.